Robotic versus open pancreaticoduodenectomy: Is there any difference for frail patients?


Journal

Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 08 10 2020
revised: 09 12 2020
accepted: 22 12 2020
pubmed: 12 1 2021
medline: 15 12 2021
entrez: 11 1 2021
Statut: ppublish

Résumé

Old age and frailty are predictors of early postoperative results after pancreatic surgery. We analysed the results of robotic and open pancreatoduodenectomy in elderly and frail patients. Data from the local robotic pancreatoduodenectomy database were reviewed and matched with those from open operations during the same period (2014-2020). Both old age and frailty were used to determine any correlation with postoperative outcomes. Elderly patients were defined as patients aged 70 years or more, while frailty was classified according to the validated modified Frailty Index. A total of 118 pancreatoduodenectomies were included in the analysis: 65 (55.1%) robotic and 53 (44.9%) open. More than 50% of patients were frail. Overall, 7.6% of patients experienced grade IV Clavien-Dindo complications, and 3.4% died within 90 days after surgery. Frail patients experienced a similar rate of severe complications after robotic vs. open operations (5.3 vs. 11.6; p = 0.439) but earlier refeeding (3 days vs. 4 days; p = 0.006) and earlier drain removal (6 days vs. 7 days; p = 0.046) when operated on by a robotic approach. The oncological outcomes, including limphnodes retrieval, residual disease, recurrences, and survival, were not influenced by the surgical approach. Non-elderly patients also showed more benefits with the robotic approach (lower complication index, earlier refeeding, and drain removal). Robotic pancreatoduodenectomy is associated with risks of major complications that are comparable to those of open operation in frail patients. Some perioperative parameters (refeeding, drain removal) seem to favour robotics in frail patients and younger patients, although at the price of longer operating times.

Sections du résumé

BACKGROUND BACKGROUND
Old age and frailty are predictors of early postoperative results after pancreatic surgery. We analysed the results of robotic and open pancreatoduodenectomy in elderly and frail patients.
METHODS METHODS
Data from the local robotic pancreatoduodenectomy database were reviewed and matched with those from open operations during the same period (2014-2020). Both old age and frailty were used to determine any correlation with postoperative outcomes. Elderly patients were defined as patients aged 70 years or more, while frailty was classified according to the validated modified Frailty Index.
RESULTS RESULTS
A total of 118 pancreatoduodenectomies were included in the analysis: 65 (55.1%) robotic and 53 (44.9%) open. More than 50% of patients were frail. Overall, 7.6% of patients experienced grade IV Clavien-Dindo complications, and 3.4% died within 90 days after surgery. Frail patients experienced a similar rate of severe complications after robotic vs. open operations (5.3 vs. 11.6; p = 0.439) but earlier refeeding (3 days vs. 4 days; p = 0.006) and earlier drain removal (6 days vs. 7 days; p = 0.046) when operated on by a robotic approach. The oncological outcomes, including limphnodes retrieval, residual disease, recurrences, and survival, were not influenced by the surgical approach. Non-elderly patients also showed more benefits with the robotic approach (lower complication index, earlier refeeding, and drain removal).
CONCLUSIONS CONCLUSIONS
Robotic pancreatoduodenectomy is associated with risks of major complications that are comparable to those of open operation in frail patients. Some perioperative parameters (refeeding, drain removal) seem to favour robotics in frail patients and younger patients, although at the price of longer operating times.

Identifiants

pubmed: 33429323
pii: S0960-7404(20)30465-5
doi: 10.1016/j.suronc.2020.12.009
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101515

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Claudia Paolini (C)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Lapo Bencini (L)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy. Electronic address: bencinil@aou-careggi.toscana.it.

Linda Gabellini (L)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Irene Urciuoli (I)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Sabrina Pacciani (S)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Angela Tribuzi (A)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Luca Moraldi (L)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Massimo Calistri (M)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Andrea Coratti (A)

Surgical Oncology and Robotics, Careggi University Hospital, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH